Respirics, Inc. was founded in 2001 to provide innovative pulmonary drug delivery systems, including the formulation and development of novel and existing drugs for administration to the lung.
Incorporated in May 2001 after its founding in September 2000 by three former executives, Gil Mott, David Gardner and Robert Casper, Respirics is a company that combines proprietary inhalation technology with powder drug formulation expertise to develop unique drug delivery solutions. The company is committed to bring effective, easy-to-use and affordable inhalation drug products to the patients who need them.
R&D
To view this information, you must subscribe to PL Intelligence.
Partnerships
To view this information, you must subscribe to PL Intelligence.
Deals
To view this information, you must subscribe to PL Intelligence.
Senior management
To view this information, you must subscribe to PL Intelligence.
Board of directors
To view this information, you must subscribe to PL Intelligence.
Contact details
To view this information, you must subscribe to PL Intelligence.
Head office
Respirics
6008 Triangle Drive
Suite 101
Raleigh
North Carolina
27617 North Carolina
All rights reserved. Terms and Conditions | Contact us
